B3GNT6, soluble fragment, Human Recombinant

B3GNT6, soluble fragment, Human Recombinant is available at Gentaur for Next week delivery.

An important precursor in the biosynthesis of mucin-type glycoproteins

Biomolecule/Target: B3GNT6

Alternates names: Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N acetylglucosaminyltransferase, Core 3 synthase, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, BGnT-6, Beta-1,3-Gn-T6

Synonyms: Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N acetylglucosaminyltransferase, Core 3 synthase, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, BGnT-6, Beta-1,3-Gn-T6

Background Information: β­1,3­N­acetylglucosaminyltransferase 6 (β3GnT6) transfers N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to N-acetylgalactosamine (GalNAc). β3GnT6 is also known as the core 3 synthase, because it creates the core 3 oligosaccharide structure in the mucin-type O-glycan, GlcNAcβ1­3GalNAcα1­serine/threonine. Core 3 synthase is a type II transmembrane protein, and is localized to stomach, small intestine and colonic tissues. It has long been known that synthesis of the core 3 structure is down-regulated in colonic cancer cells and it has been shown that the expression of β3GnT6 is also down-regulated. Colonic cancer cells transfected with β3GnT6 have reduced metastatic potential compared to non-transfected cells, and when injected into mice show decreased tumor formation. Pancreatic cancer cells transfected with β3GnT6 show a similar phenotype, which has been attributed to the addition of core3 O-glycans to α2β1 integrin.

Reconstitution Instructions: N/A

NCBI Gene Symbol: B3GNT6

Gene ID: 192134

NCBI Accession: Q6ZMB0